Choroideremia Research
Choroideremia natural history studies
We are enrolling qualified patients with choroideremia in order to measure disease progression in a group of patients with this disease.
Choroideremia gene therapy trials
Qualifying patients may enter a gene therapy trial in an attempt to slow or halt the progression of Choroideremia
In order to be seen at the Retina Foundation of the Southwest, you must have a referral from your ophthalmologist.
If you have a question related to choroideremia, please contact us at 214-363-3911.

Related Articles
Join Drew Brees and the Retina Foundation for the Third Annual Visionary Luncheon – March 4, 2020 Watching Movies Could Help Treat Children with Lazy Eye Recently@Retina Newsletter September 2023 Discovering New Therapies for AMD Early Detection and Treatment for Pediatric Eye Conditions – Video Update